Physician profile
Michael J Weiss
NPI 1043258890
$668.11
in general payments reported to CMS, 2019-2025
11 companies · $60.95 in 2025
The $60.95 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $28.70 · 2021: $199 · 2022: $158 · 2023: $26.26 · 2024: $34.87 · 2025: $60.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $218.18 | 2020-2022 | |
| Janssen Biotech, INC. | $86.04 | 2021-2022 | |
| Celltrion USA INC. | $60.95 | 2025 | Vegzelma |
| Pfizer INC. | $59.77 | 2019 | |
| Shionogi INC | $54.80 | 2019 | |
| Inari Medical, INC. | $47.77 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.04 | 2019 | |
| Penumbra, INC. | $29.36 | 2022-2023 | Indigo System |
| Boston Scientific Corporation | $24.20 | 2022 | |
| Abbvie INC. | $22.57 | 2022 | |
| Alnylam Pharmaceuticals INC. | $18.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.